RNS Number:6669S
Corin Group PLC
01 December 2003



                                Corin Group PLC

                 UPDATE ON US METAL-ON-METAL REGULATORY STATUS

As reported in the interim statement dated 23 September 2003, Corin has been in
discussions with the FDA concerning the appropriate approval route for its large
diameter stemmed metal-on-metal hip in the US.

The FDA has advised Corin that the Group will need to provide US-generated
clinical data.  Accordingly, Corin is now seeking FDA approval to run a full
US-based clinical trial, which is expected to commence in the first quarter of
2004.

The US clinical trial for Corin's metal-on-metal resurfacing device, Cormet,
remains on schedule, with full approval expected to be granted in 2006.

                                                                 1 December 2003


Enquiries:


Corin Group PLC
Ian Paling, Chief Executive                               Tel:    01285 659 866
Simon Hartley, Finance Director


College Hill                                              Tel:    020 7457 2020
Adrian Duffield/Clare Warren




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCFSISUFSDSESE